Agoracom Blog Home

Posts Tagged ‘tsx’

CardioComm Solutions $EKG.ca – Congress Eyes Privacy Protections for Data on #Mhealth #Wearables $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 11:38 AM on Monday, November 18th, 2019

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

Congress Eyes Privacy Protections for Data on mHealth Wearables

A bill introduced this week – and another introduced this past June – aim to protect patient health data gathered on consumer-facing mHealth wearables like smartwatches, fitness bands and even apps.

  • US Senators Bill Cassidy (R-LA) and Jacky Rosen (D-NV) have introduced a bill this week that aims to define how data gathered on smartwatches, fitness bands and other connected health devices – including mHealth apps – dis protected and prevent “entities that collect consumer health information” from exposing that data to other parties.

By Eric Wicklund

November 15, 2019 – Congress is jumping into the long-simmering debate over the protection of health data on consumer-facing mHealth wearables.

US Senators Bill Cassidy (R-LA) and Jacky Rosen (D-NV) have introduced a bill this week that aims to define how data gathered on smartwatches, fitness bands and other connected health devices – including mHealth apps – dis protected and prevent “entities that collect consumer health information” from exposing that data to other parties.

“The introduction of technology to our health care system in the form of apps and wearable health devices has brought up a number of important questions regarding data collection and privacy,” Rosen said in a press release announcing the bill, to be called The Stop Marketing And Revealing The Wearables And Trackers Consumer Health (SMARTWATCH) Data Act. “This commonsense, bipartisan legislation will extend existing health care privacy protections to personal health data collected by apps and wearables, preventing this data from being sold or used commercially without the consumer’s consent.” 

The bill’s introduction comes amidst a flurry of news in the consumer-facing mHealth arena, including Google’s pending purchase of Fitbit and the announcement that the tech giant will be working with Ascension – the largest non-profit health system in the US – to integrate mHealth technology and data collection into the health system’s care programs.

“The Google/Ascension news has brought needed scrutiny to the security of Americans’ health data,” Cassidy said in the press release. “The SMARTWATCH Act prevents big tech data harvesters from collecting intimate private data without patients’ consent. Americans should always know their health information is secure.”

The bill defines consumer health information as “any information about the health status, personal biometric information, or personal kinesthetic information (such as keystroke or gait patterns and sleep information) about a specific individual that is created or collected by a personal consumer device, whether detected from sensors or input manually.” This would include not only physiological, biological and behavioral data, but “deoxyribonucleic acid, imagery of the iris, retina, fingerprint, face, hand, palm, vein patterns, and voice recordings, from which an identifier template, such as a faceprint, a minutiae template, or a voiceprint, can be extracted.”

Under the bill, the organization that collects that data would be barred from transferring, selling, sharing or allowing access to that data, unless aggregated and anonymized, to “any domestic information broker or other domestic entity” whose primary function is to analyze that information for profit or whose primary purpose is to add commercial value to the entity collecting the data.

The bill goes on to direct the Health and Human Services Secretary to treat violations in the same way that it would treat HIPAA (Health and Insurance Portability and Accountability Act) violations.

The legislation mirrors a bill introduced in June by Senators Amy Klobuchar (D-MN) and Lisa Murkowski (R-AK) that aims to protect consumer health information not protected under current laws.

The Protecting Personal Health Data Act (S.1842) would require the development of regulations that strengthen privacy and security protections, including setting consent standards that address genetic, biometric and general personal health data, and give consumers the ability to access, amend and delete their data. It would also create a National Task Force on Health Data Protection that would:

  • evaluate and provide input to address cybersecurity risks and privacy concerns associated with consumer products that handle personal health data, and the development of security standards for consumer devices, services, applications, and software; and
  • study the long-term effectiveness of de-identification methodologies for genetic and biometric data, and advise on the creation of resources to educate consumers about direct-to-consumer genetic testing.

Source: https://mhealthintelligence.com/news/congress-eyes-privacy-protections-for-data-on-mhealth-wearables

CLIENT FEATURE: Tartisan Nickel $TN.ca Kenbridge Property Hosts M&I Resource of 7.14 Million Tonnes of 0.62% #Nickel + 0.33% #Copper $ROX.ca $FF.ca $EDG.ca $AGL.ca $ANZ.ca

Posted by AGORACOM-JC at 10:14 AM on Monday, November 18th, 2019

Investment Highlights

  • Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
  • 17.5 (21.8 fully diluted) percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property

Kenbridge Ni Project (ON, Canada)

  • Advanced  stage  deposit  remains open  in  three  directions,  is  equipped with a 623m  deep  shaft  and  has  never  been  mined. 
  • Preliminary  Economic Assessment completed and updated returned robust project 
    economics and operating costs including  a  NPV  of  C$253M  and  cash costs of US$3.47/lb of nickel net of  copper credits.
  • Plans for Kenbridge include updating PEA, advancing the project through to feasibility and exploring the open mineralization at depth

FULL DISCLOSURE: Tartisan Nickel Corp. is an advertising client of AGORA Internet Relations Corp.

PRIMO Nutraceuticals Inc. $PRMO.ca – Feds Finally Crafting National #CBD Rules $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 5:05 PM on Friday, November 15th, 2019

SPONSOR:  PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

Feds Finally Crafting National CBD Rules

  • After years of states passing their own rules concerning cannabidiol – more commonly known as CBD – the federal government is now quietly taking the first steps to regulate it.

By: Louis Biscotti

Photo: Sven Hoppe/dpa (Photo by Sven Hoppe/picture alliance via Getty Images) dpa/picture alliance via Getty Images

The F&B industry is ahead of them: You can already get CBD in gummies, oils, lotions and juices, and Arizona Iced Tea and Ben and Jerry’s have been testing it. But as states moved to regulate, the federal government sat on the sidelines, leaving CBD in legal limbo.  That began to change a couple of weeks ago in what could be the beginning of the biggest change for the CBD market since the Farm Bill of 2018 ended classifying hemp and products derived from it as controlled substances.

The United States Department of Agriculture (USDA) in late October published its interim final rules for domestic hemp production in the Federal Register, including rules regarding CBD, a product of hemp. How big a deal could this be? Think about the end of Prohibition. The federal government is finally creating standards that could help create a national marketplace. That could help move CBD from the margins to the mainstream, adding security, safety and consistency to manufacturing.

The proposed rules come as sales of CBD are expected to reach $13 billion this year, even as federal law tries to catch up with demand. CBD is getting too big to be ignored, and lack of reliable information and uniform regulation adds to confusion. The feds are finally arriving on the scene (let’s not call it a party) with the structure that’s needed.

The new rules would include federal aid for hemp farmers and could help ease access to insurance and loans, leading to bigger supply and more financing. There are also tough provisions, which could be good for consumers and companies, but will add costs for manufacturers and others in the supply chain. Hemp samples, for instance, would have to be delivered to DEA-certified labs 15 days before harvest and certified.

The USDA, however, is only the first federal agency to lay its hands on hemp and CBD. The Food & Drug Administration (FDA), which approved seizure drug Epidolex containing CBD, classifies it as an active ingredient in medications – which it regulates. The agency in late October said it’s continuing “to explore potential pathways for various types of CBD products to be lawfully marketed.” Manufacturing isn’t currently subject to FDA review. The USDA’s actions could help change that. The Grocery Manufacturers Association, for instance, is pushing for the FDA to issue final CBD rules instead of allowing “a maze of inconsistent, and often contradictory, state and local regulations” that can lead to a “regulatory mess.”

The USDA has also begun to regulate THC, the psychoactive ingredient in hemp sometimes included with CBD. The USDA indicates that, potentially, hemp could contain up to 0.3 percent THC or tetrahydrocannabinol, the limit in Canada and many other countries. The FDA is likely to fall in line with that as CBD becomes more common.

CBD’s popularity comes with often-exaggerated claims; some people look at it as a cure-all. That also could change with regulation. The FDA already issued warnings to companies making medical claims. As the feds begin to regulate CBD, some misinformation may vanish from marketing, which could lower sales, as the market sorts itself out, “weeding out” certain companies as others grow.

Money is already flowing into companies working with CBD. Altria, parent of cigarette giant Philip Morris, poured $1.8 billion into cannabis company Cronos Group. Beer distributors and Arizona Iced Tea are infusing drinks with CBD, hoping to experience (puns are just too easy here) higher sales. As the market for CBD continues to expand, it’s only a matter of time before CBD gets what the Grocery Manufacturers Association wished for: federal regulation.

While most industries dread regulation, it could prove essential for CBD to truly take off in food and beverage, providing safety to consumers and security for producers. The USDA has stepped off the sidelines, and the FDA is talking about stepping in. It looks like federal rules may finally be arriving, bringing standards and — get ready — red tape (which means compliance costs)  in a trade-off for quality control, consumer protection, and growth prospects. It’s starting to look like a national marketplace for CBD may no longer be a pipe dream.

Source: https://www.forbes.com/sites/louisbiscotti/2019/11/15/feds-finally-crafting-national-cbd-rules/#7a79898f1b89

New Age Metals $NAM.ca – Europe #EVs now use 57% more #lithium carbonate equivalent $LIC.ca $LIX.ca $LI.ca $ELR.ca $ATL.ca

Posted by AGORACOM-JC at 3:30 PM on Friday, November 15th, 2019

SPONSOR: New Age Metals Inc. The company’s Lithium Division has already made significant acquisitions in Canada and the USA. The company also owns one of North America’s largest primary platinum group metals deposit in Sudbury, Canada. Updated NI 43-101 Mineral Resource Estimate 2,867,000 PdEq Measured and Indicated Ounces, with an additional 1,059,000 PdEq Ounces in the Inferred. Learn More.

Europe EVs now use 57% more lithium carbonate equivalent

  • Changing mix of EV sales is most noticeable in Europe where the average battery in new passenger EVs sold in September contained 15.8kg of LCE
  • Constitutes a 57% surge compared to last year, thanks in no small part to the popularity of the Tesla Model 3 on the continent

CItroën e-Méhari. Batteries for the electric SUV are produced in France. Image: PSA Group

By: Frik Els

Electric car pioneer Tesla is already producing units on a trial basis at its giant Shanghai gigafactory despite only breaking ground this year, but thanks to changes to the Chinese EV subsidy program, demand for locally-made Teslas may fall short of expectations.

On Monday, China’s automobile manufacturing industry body said fewer new energy vehicles, or NEVs as they are termed domestically, could be sold this year than in 2018 (last year sales boomed by more than 60%).

Sales of NEVs – which apart from battery-powered vehicles also include hybrids and fuel cell cars – fell by more than 45% in October from the same month last year, adding to the woes of an industry coping with 16 straight months of declining overall sales.

Changes to China’s EV incentive program favour hybrids so lithium loads may start to tend downwards in that country too

Adamas Intelligence tracks the battery capacity (and the metals used in them) of electric vehicles sold around the world and the slowdown in the EV market, where lithium-ion batteries dominate, has already showed up in raw material deployment data.

In September 2019, the average new passenger EV including plug-in and conventional hybrids sold globally contained 12.2 kilograms of lithium carbonate equivalent (LCE), a modest increase of 4% over 2018, according to the latest Adamas report.

The Toronto-based research company’s data shows China still outstripped global growth in September with a 7% increase in LCE on a per-EV basis, reaching a sales-weighted average of just shy of 20kg thanks to the prevalence of full electric models in the country.

That’s in stark contrast to Japan, where hybrids represent more than 90% of EV sales and average batteries contain only 1.1kg of LCE. Changes to China’s EV incentive program favour hybrids so lithium loads may start to tend downwards in that country too.

The changing mix of EV sales is most noticeable in Europe where the average battery in new passenger EVs sold in September contained 15.8kg of LCE.

That constitutes a 57% surge compared to last year, thanks in no small part to the popularity of the Tesla Model 3 on the continent. Teslas have always had bigger batteries than competitor cars to help with fast-charging and range.

In the US the trend is in the opposite direction – with passenger EVs leaving showrooms containing on average 15.2kg of LCE, 12% less than in September 2018.

Source: https://www.mining.com/lithium-price-europe-evs-now-use-57-more-lce/

CLIENT FEATURE: CardioComm Solutions $EKG.ca – Connecting Your Heart To The Cloud $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 12:49 PM on Friday, November 15th, 2019

Global Leaders in Mobile  ECG Connectivity

  • 20 years of medical credibility licensing technologies to hospitals, physicians, remote patient monitoring  platforms, research groups and commercial call centers
  • Sold into > 20 countries, with the largest customer base located in the US
  • Class II medical device clearances and device agnostic for collecting, viewing, recording, analyzing and  storing of ECGs for management of patient and consumer health
  • ECG solutions for both consumer (OTC) and medical (Rx) markets
  • Owns all IP and source code
  • Market expert contributor for reports in m‐health, mobile cardiac monitoring and new advances in  consumer health and wellness monitoring

Recent Highlights

  • Secured New Health Canada Device Clearance and Exclusive Canadian Sales Rights for US Medical ECG Device Manufacturer Read More
    • Entered into an exclusive sales and marketing agreement for the GEMS™ Sirona with California-based Datrix LLC
    • Under the multi-year, renewable agreement, CardioComm assumes the role of exclusive Canadian distributor of the Datrix ECG recorders under the GEMS™ Sirona brand device.
  • Secured Newest US and Canadian Medical Device 13485:2016 MDSAP Certification Read More
    • Completed its ISO 13485:2016 certification in compliance with the Medical Device Single Audit Program, a mandatory requiment under Health Canada and accepted as an equivalent quality management certification by the USA Food and Drug Administration.
  • Announced ECG Services Integration and Co-Marketing Agreement with California-Based BodiMetrics LLC Read More
    • GEMS™ Universal will be available under two subscription models:
    • $6 US per month with one free ECG interpretation included; and,
    • $69 US per year with 12 free ECG interpretations that may be requested any time during the one year subscription.

Company Accolades

FULL DISCLOSURE: CardioComm Solutions Inc. is an advertising client of AGORA Internet Relations Corp.

BetterU Education Corp. $BTRU.ca – #Edtech Startups Transforming The Way Indian Children Learn $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 10:57 AM on Friday, November 15th, 2019
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

Edtech Startups Transforming The Way Indian Children Learn

  • Many edtech startups today are leveraging the increasing literacy rate coupled with increased internet penetration
  • These startups are trying to address the most important issue faced by the Indian education system

India has roughly 1.5 million schools, 38,000 colleges, and 760 universities as per MHRD. This translates into one school per 200 school-goers and one college per 3,700 college-goers. According to a report by management consulting firm Technopak in 2016, India’s education market is valued at $100 Bn while the digital learning market is estimated at $2 Bn. The report also said that the digital learning market is expected to reach $5.7 Bn by 2020 as the number of internet users is increasing.

Many edtech startups today are leveraging the increasing literacy rate coupled with increased internet penetration. These startups are trying to address the most important issue faced by the Indian education system, which is the lack of upgrade. By bringing in technology, these startups are trying to bridge the gap between rural and urban India as well.

Samsung-backed TagHive recently launched an AI-powered classroom engagement solution, Class Saathi, to make tech-based learning accessible and affordable for schools in rural India with little or no infrastructural investments. The Central Board of Secondary Education (CBSE) also partnered with Microsoft India and IBM to focus on tech reskilling for teachers and AI curriculum in schools. Through this, CBSE will be conducting capacity building programmes for high school teachers with an aim to integrate cloud-powered technology in K12 teaching and inculcating digital teaching skills in educators through the curriculum as well as extra-curricular training.

Source:https://inc42.com/buzz/india-ranks-fourth-in-providing-entrepreneurial-training-in-schools/

ThreeD Capital Inc. $IDK.ca – ‘Unknown Fund’ to Donate $75M in #Bitcoin to #Crypto, Anonymity Startups Focused $HIVE.ca $BLOC.ca $CODE.ca

Posted by AGORACOM-JC at 10:47 AM on Friday, November 15th, 2019

SPONSOR: ThreeD Capital Inc. (IDK:CSE) Led by legendary financier, Sheldon Inwentash, ThreeD is a Canadian-based venture capital firm that only invests in best of breed small-cap companies which are both defensible and mass scalable. More than just lip service, Inwentash has financed many of Canada’s biggest small-cap exits. Click Here For More Information.

‘Unknown Fund’ to Donate $75M in Bitcoin to Crypto, Anonymity-Focused Startups

  • An anonymous organization dubbed “Unknown Fund” is planning to give away $75 million in Bitcoin (BTC) to startups that are focused on anonymity and the protection of personal data.

By Ana Alexandre

An anonymous organization dubbed “Unknown Fund” is planning to give away $75 million in Bitcoin (BTC) to startups that are focused on anonymity and the protection of personal data.

In a press release on Nov. 13, the organization — which consists of “ordinary, anonymous people from different countries” —  said it will donate the money to startups which support the idea of anonymity and specifically operate in such fields as the protection of personal information, tools of anonymity, cryptocurrencies and blockchain.

Fighting the misuse of people’s personal data

The idea behind the donations is to fight the manipulation of people by politics, social media networks and other parties who collect individuals’ personal data, which Unkown Fund says has proved to be an “amazing and frightening” tool.

The project supposedly started on 4chan, an anonymous English-language imageboard, and claims to have the support of hacktivist group Anonymous, which it cites as saying:

“Now the main goal of large corporations is to collect as much information as possible about the personal lives of people, and then use it for their enrichment. And they do a great job of it by making ordinary people get poorer. We are ready to fight for change and protect people.”

The Unknown Fund argues that the deployment of blockchain technology and digital currencies could help protect people’s rights and freedoms, and eventually develop a new environment with a trustworthy monetary system.

Blockchain in personal data protection

Many industry players have questioned blockchain’s ability to ensure personal data protection. Speaking with Cointelegraph in August, Timothy Paolini, a board member at NYU Blockchain, stated:

“Blockchains are built around the principles of decentralization, removing the single point of failure risk (think Equifax servers) and cutting out unnecessary third parties by establishing a more direct, peer-to-peer network. This also maintains your privacy and control of your data from third-party apps as data rests at the protocol instead of the application layer.”

Deirdre K. Mulligan, an assistant professor at the University of California, Berkeley School of Information, argued that blockchains do not inherently protect your identity, as they can be manipulated by their architects to be centralized and non-anonymous. Mulligan stated:

“Companies can exert a lot of control over how they design an application, through its architecture, default settings, what it communicates in its privacy policies, and what it does in practice. The value for a consumer concerned about her privacy would depend on the blockchain application and the kind of data collected and processed by it.”

Source: https://cointelegraph.com/news/unknown-fund-to-donate-75m-in-bitcoin-to-crypto-anonymity-focused-startups

CardioComm Solutions $EKG.ca – #Mhealth Solutions Market Forecasting CAGR of 34.34% $ATE.ca $TLT.ca $OGI.ca $ACST.ca $IPA.ca

Posted by AGORACOM-JC at 4:33 PM on Thursday, November 14th, 2019

SPONSOR: CardioComm Solutions (EKG: TSX-V) – The heartbeat of cardiovascular medicine and telemedicine. Patented systems enable medical professionals, patients, and other healthcare professionals, clinics, hospitals and call centres to access and manage patient information in a secure and reliable environment.

mHealth Solutions Market Forecasting CAGR of 34.34%

  • mHealth solutions market is expected to rise from its initial estimated value of USD 28.06 billion in 2018 to a projected value of USD 297.70 billion by 2026, registering a CAGR of 34.34% in the forecast period of 2019-2026
  • This rise in market value can be attributed to lower physician ratio as compared to patients requiring healthcare provisions.

Market Definition: Global mHealth Solutions Market

mHealth solutions can be defined as the technology utilized in providing healthcare services and products through smart devices and smart phones. This technology is used for collecting patient data, their patient history and also through this technology, healthcare providers can ease their workflow helping them work in a systematic and effective way.

Key Market Competitors: Global mHealth Solutions Market

Medtronic; Cerner Corporation; Koninklijke Philips N.V.; ZTE Corporation; Nokia; AirStrip Technologies; BioTelemetry, Inc.; Apple Inc.; iHealth Labs Inc.; athenahealth, Inc.; AliveCor, Inc.; Zebra Technologies Corp; Johnson & Johnson Services, Inc.; Cisco; AT&T Intellectual Property; AgaMatrix; OMRON Corporation; Withings and Qualcomm Technologies, Inc. are few of the major competitors currently working in the mHealth solutions market.

Market Drivers:

  • Growth in adoption and usage of smart devices and smart phones in healthcare and medical monitoring; this factor is expected to act as a driver for the market growth
  • Increasing focus on patient-focused and individual specific healthcare provisions; this factor is expected to drive the market growth

Market Restraints:

  • Absence of any regulations and standardization in the market restraining the market growth
  • Lack of enthusiasm in providing information regarding the identification of correct mHealth applications and solutions; this factor is expected to restrain the market growth

Key Developments in the Market:

  • In January 2019, Zebra Technologies Corp announced that they are planning to launch “DS1800-HC” collection of scanners and “TC51-HC” cellular PC for healthcare professionals in India. These products will assist physicians in easing their workflow resulting in increased productivity and effectiveness.
  • In March 2016, ZTE Corporation announced the launch of all-in-one mHealth product that utilizes a number of smart devices and incorporates IoT technology in identifying the diseases & disorders and providing patient specific medical care.

Global mHealth solutions market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of mHealth solutions market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Source: https://weeklyspy.com/2019/11/14/mhealth-solutions-market-forecasting-cagr-of-34-34-with-nokia-jawbone-ihealth-labs-cisco-athenahealth-alivecor-inc-omron-healthcare-inc-agamatrix/

BetterU Education Corp. $BTRU.ca – #Samsung – Backed #TagHive Enters #India To Digitise Public Schools With #Edtech Device And Platform $ARCL $CPLA $BPI $FC.ca

Posted by AGORACOM-JC at 3:27 PM on Thursday, November 14th, 2019
SPONSOR:  BetterU Education Corp. aims to provide access to quality education from around the world. The company plans to bridge the prevailing gap in the education and job industry and enhance the lives of its prospective learners by developing an integrated ecosystem. Click here for more information.

Samsung-Backed TagHive Enters India To Digitise Public Schools With Edtech Device And Platform

  • TagHive has launched Class Sathi in two Madhya Pradesh districts
  • The startup was a part of Samsung’s C-lab incubator programme
  • TagHive aims to bring affordable digital learning to primary schools in rural India

In the Indian context, the education infrastructure and quality of learning has always come under scrutiny, especially due to concerns of outdated syllabi and teaching methods at the primary level in public schools.

Most edtech startups in India are looking to solve this by bringing learning to the mobile phone or PC, but that’s not always possible at schools in smaller towns and villages, which do not have the wherewithal to implement such high-tech solutions. That’s what TagHive is looking to overcome with its affordable edtech platform (device and software) for the Indian public and primary school market.

Suwon, South Korea-based TagHive has launched its flagship product Class Saathi in two districts of Madhya Pradesh. Tying up with the state government, TagHive’s Class Saathi mobile clicker solution and the companion app will be available across 13 schools in its two districts.

Founded in 2017 by IIT and Harvard alumni, Pankaj Agarwal, the startup for his innovation in the education segment has received funds from Samsung Ventures and Enlight Ventures. The startup was also incubated by Samsung’s internal C-Lab programme after the South Korean chaebol discovered Agarwal’s idea during his stint at the company.

Speaking to Inc42, the founder said that Samsung C-Lab supported TagHive with the necessary resources such as funding, workspace, technical support and culture-building through the incubation programme. “After 15 months of working on my idea at Samsung, it was chosen to be spun off as an independent company, TagHive. Samsung Ventures has put in seed capital of over INR 2.5 Cr,” Agarwal said.

The AI-powered classroom engagement solution Class Saathi aims to make tech-based learning accessible and affordable for schools in rural India with little or no infrastructural investments. The startup also aims to increase student participation and learning outcomes, while at the same time supporting and motivating teachers to improve their teaching methodology.

TagHive doesn’t just limit itself to teachers and students but also involves another key stakeholder in the education chain — the child’s parents. Agarwal said that this helps keep everyone in the loop about the student’s progress.

Source: https://inc42.com/buzz/samsung-backed-taghive-enters-india-to-digitise-public-schools-with-edtech-device-and-platform/

Empower Clinics $CBDT.ca – The case for treating #PTSD with #cannabis $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 1:55 PM on Thursday, November 14th, 2019

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics
  • Patient database of over 165,000 patients 
  • Platform generating $4MM USD in revenue annually (2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Launching CBD extraction facility
  • First extraction system capacity = 6,000 Kg per year.

The case for treating PTSD with cannabis

  • Previous research has linked cannabis use with poorer mental health in PTSD patients, but it’s unclear whether cannabis exacerbates PTSD symptoms, or if patients with worse symptoms are simply self-medicating more.
  • Much of he existing evidence for cannabis as a PTSD treatment comes from patient reports of success.

Research shows that cannabis use by people living with post-traumatic stress disorder may reduce their likelihood of depression and suicide

Stock photo This article, written by Stephanie Lake, University of British Columbia and M-J Milloy, University of British Columbia, originally appeared on The Conversation and has been republished here with permission:

Post-traumatic stress disorder (PTSD), a psychiatric condition linked to surviving or witnessing a traumatic life event, will affect around one in 10 Canadians at some point in their lives. PTSD can cause agitation, flashbacks, impaired concentration and memory, insomnia and nightmares and these symptoms can increase the risk of substance abuse and dependence, depression and suicide.

Many patients struggle to find adequate symptom relief from conventional treatments for PTSD including anti-depressant or anti-psychotic medications and psychological treatments such as trauma-focused cognitive behavioural therapy.

Unsurprisingly, many turn to alternative ways of coping — such as medical cannabis use. This is especially evident in the dramatic rise in number of Canadian military veterans receiving government reimbursement for medical cannabis, with PTSD as a common reason for use.

The results of clinical trials testing cannabis as a PTSD treatment are pending. Previous research has linked cannabis use with poorer mental health in PTSD patients, but it’s unclear whether cannabis exacerbates PTSD symptoms, or if patients with worse symptoms are simply self-medicating more. Much of the existing evidence for cannabis as a PTSD treatment comes from patient reports of success.

As epidemiologists and substance use researchers, we have been exploring the relationship between cannabis and PTSD using readily available Statistics Canada mental health data.

In a recent study, published in the Journal of Psychopharmacology, we found that PTSD increased the risk of major depressive episodes among Canadians who didn’t use cannabis by roughly seven times, and suicidal ideation by roughly five times. But, among Canadians who did use cannabis, PTSD was not statistically associated with either outcome.

How cannabis works in the body

Substance use, including cannabis use, is common among trauma survivors. It’s easy to write off the drug as just a tool to briefly escape negative feelings, at the risk of worsening longer-term symptoms. However, the relationship between cannabis and PTSD is more complex than it appears on the surface.

Our bodies naturally produce molecules called endogenous cannabinoids that fit into special cannabinoid receptors throughout the brain and body. This endocannabinoid system is involved in stabilizing bodily processes, including regulating many functions of the brain that tend to be affected after traumatic experiences, such as fear, memory and sleep.

Certain components of the cannabis plant, including the well-known molecules tetrahydrocannabinol (THC, the component of cannabis that produces the high) and cannabidiol (CBD, the component of cannabis that won’t get you high, but has potential for treating epilepsy, inflammation, nausea and anxiety) are also cannabinoids because of their structural similarity to endogenous cannabinoids.

Even though THC and CBD aren’t naturally produced in our bodies, they can interact with the endocannabinoid system to influence a number of biological processes.

Research is still uncovering if and how cannabis works within the body to affect the course of PTSD. Brain imaging research suggests that patients with PTSD have an abundance of cannabinoid receptors but produce few endogenous cannabinoids to lock into them, meaning that supplementing the body with plant-based cannabinoids like THC might help some brain processes function as normal.

Reduced depression and suicide

Roughly one in four individuals with PTSD in the Statistics Canada survey data that we analyzed used cannabis, compared to about one in nine in the general population.

In our study, we used statistical models to quantify the relationship between having PTSD and recently experiencing a major depressive episode or suicidal ideation. We hypothesized that if cannabis helped mitigate symptoms of PTSD, we’d see a much weaker association between PTSD and these indicators of mental distress in the cannabis-using population.

Indeed, exploring the associations in this way while controlling for other factors (such as sex, age, income, other substance use, other mental health problems) supported our hypothesis.

In a follow-up analysis of the 420 individuals in the sample who had PTSD, we categorised cannabis use into “no use,” “low-risk use” and “high-risk use” (meaning that they screened positive for cannabis abuse or dependence).

We found that low-risk cannabis users were actually less likely than non-users to develop a major depressive episode or to be suicidal, though there was a trend towards increased risk of both outcomes for the high-risk users.

A promising new signal

People with PTSD are more likely to experience depression and suicidal ideation. However, our findings suggested that these indicators of mental health were improved when they were engaging in lower-risk cannabis use.

Our study has a number of limitations that prevent us from being able to understand whether cannabis is what’s causing the reduced association between PTSD, depression and suicide.

For example, our data captures information covering participants’ experiences from the previous year, meaning we can’t actually decipher what came first: the cannabis use, the PTSD or the major psychological episodes.

We didn’t have detailed information about how participants used cannabis: for example, the type and dose of cannabis they used, how often they used it or how they consumed it. These details will be crucial to future research in this area.

Our study’s strength comes from its ability to describe patterns of PTSD symptoms and cannabis use in a large sample that’s considered to be representative of the Canadian population. Although our findings suggest that cannabis could be of possible therapeutic use in the treatment of PTSD, cannabis use is not without risks, including the development of cannabis use disorder.

We’ve uncovered a promising new signal on the potential of cannabis-based therapies, but we look forward to much work ahead in understanding how they might fit into PTSD and mental health treatment more broadly.

Source: https://www.collingwoodtoday.ca/local-news/canada-the-case-for-treating-ptsd-with-cannabis-1831760